Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Lupus Stories

2010-07-07 10:03:00

WASHINGTON, July 7 /PRNewswire/ -- The Lupus Foundation of America Greater Washington Chapter (LFAGW) has merged with Lupus Mid-Atlantic to serve the entire District of Columbia, Maryland, Northern and Central Virginia regions -- encompassing most of the tri-state area. Renamed the Lupus Foundation of America DC/MD/VA Chapter, Inc., services will include many support groups, two symposia, and free workshops and teleconferences. Potential patients served will increase to over 80,000 people...

2010-06-30 08:00:00

BRISBANE, Australia, June 30 /PRNewswire/ -- Australian drug development company CBio Limited (ASX: CBZ) today announced the achievement of a recruitment milestone in its clinical trial of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA). CBio Managing Director Jason Yeates said that the company was very pleased with recruitment levels achieved by the new clinical trial...

2010-06-24 14:50:49

Higher levels of antibodies may be linked to disease severity and progression University of Texas Medical Branch researchers have uncovered an association between free radical-mediated reactions and the severity and progression of system lupus erythematosus (SLE). Higher levels of oxidative and nitrosative stress markers were found in SLE patients with greater disease activity suggesting a causal relationship. Full findings of the study are available in the July issue of Arthritis &...

2010-06-16 08:30:00

ATLANTA, June 16 /PRNewswire-FirstCall/ -- UCB (Euronext: UCB) and Immunomedics, Inc. (Nasdaq: IMMU) announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE). Data presented at the European League Against Rheumatism (EULAR) meeting in Rome from the phase IIb study, EMBLEM(TM), suggest promising results of epratuzumab in patients with SLE. EMBLEM(TM) was a 12-week,...

2010-06-15 07:00:00

EXTON, Pa., June 15 /PRNewswire/ -- BioTrends is pleased to announce the upcoming publication of a new syndicated report, TreatmentTrends®: Systemic Lupus Erythematosus (SLE). This report will provide a comprehensive market overview of current and future treatment trends in SLE based on a primary research study fielded with 102 rheumatologists in the U.S. during the first week in June. Preliminary findings indicate that despite the availability of multiple treatment...

2010-06-10 13:42:00

HAYWARD, Calif., June 10 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing therapeutics to treat serious diseases associated with inflammation and autoimmune disorders, today announced it has updated its Lupus Scientific Advisory Board. A-623 is Anthera's Phase 2b compound being developed as a treatment for systemic lupus erythematosus (SLE). "Anthera is developing a promising therapeutic for Lupus, a condition in great need of...

2010-05-13 01:05:00

WASHINGTON, May 13 /PRNewswire-USNewswire/ -- More than 600 people turned out tonight for the Lupus Foundation of America's (LFA) National Butterfly Gala, which recognized Ted Turner, Chairman, Turner Enterprises, Inc., Senator, Daniel K. Inouye (HI), Human Genome Sciences and GlaxoSmithKline for their contributions to advancing the science and medicine of lupus, and supporting the millions of people around the world affected by lupus. (Photo:...

2010-05-10 12:27:00

WASHINGTON, May 10 /PRNewswire/ -- The Lupus Foundation of America Greater Washington Chapter (LFAGW) set a nationwide chapter record for its 4th Annual Walk for Lupus Now! at http://www.dclupuswalk.org Washington, raising more than $250,000 with 2,500 walkers and $270,000 expected by the end of May. Corporate sponsor Human Genome Sciences (HGS) also set a team record donating more than $33,000, its highest team record ever. In time for today's World Lupus Day, HGS also made a generous...

6f7317c3e2a2ce0b552ad198f40ce470
2010-05-04 07:32:11

Lupus is a disease where the immune system attacks healthy cells of the body. This leads to progressive damage of different tissues and organs. The classical characteristic of the disease is the so-called butterfly rash in the face. Many Lupus patients eventually die of kidney failure. Scientists at the Max Planck Institute for Infection Biology in Berlin together with medical scientists from the University of Erlangen succeeded in elucidating basic principles of the disease. This opens up...

2010-04-14 10:35:00

WASHINGTON, April 14 /PRNewswire/ --The Lupus Foundation of America Greater Washington Chapter (LFAGW at http://www.lupusgw.org) will offer the 15th Annual Symposium for Lupus patients and their families on Saturday, May 1 from 9:30 a.m.-1:00 p.m. at the Carnegie Endowment for International Peace (map), 1779 Massachusetts Ave., N.W., Washington, D.C. The free Symposium was created for the 75,000+ Washington area patients with lupus -- 90 percent of whom are women. Lupus is a chronic,...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »